全文获取类型
收费全文 | 1140篇 |
免费 | 49篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 73篇 |
妇产科学 | 18篇 |
基础医学 | 81篇 |
口腔科学 | 39篇 |
临床医学 | 90篇 |
内科学 | 238篇 |
皮肤病学 | 25篇 |
神经病学 | 51篇 |
特种医学 | 256篇 |
外科学 | 70篇 |
综合类 | 24篇 |
预防医学 | 135篇 |
眼科学 | 16篇 |
药学 | 34篇 |
中国医学 | 1篇 |
肿瘤学 | 39篇 |
出版年
2021年 | 4篇 |
2020年 | 3篇 |
2019年 | 4篇 |
2018年 | 13篇 |
2017年 | 14篇 |
2016年 | 13篇 |
2015年 | 13篇 |
2014年 | 17篇 |
2013年 | 21篇 |
2012年 | 20篇 |
2011年 | 14篇 |
2010年 | 39篇 |
2009年 | 46篇 |
2008年 | 31篇 |
2007年 | 26篇 |
2006年 | 21篇 |
2005年 | 15篇 |
2004年 | 22篇 |
2003年 | 20篇 |
2002年 | 18篇 |
2001年 | 24篇 |
2000年 | 17篇 |
1999年 | 14篇 |
1998年 | 51篇 |
1997年 | 65篇 |
1996年 | 50篇 |
1995年 | 41篇 |
1994年 | 54篇 |
1993年 | 60篇 |
1992年 | 18篇 |
1991年 | 15篇 |
1990年 | 18篇 |
1989年 | 42篇 |
1988年 | 40篇 |
1987年 | 34篇 |
1986年 | 33篇 |
1985年 | 35篇 |
1984年 | 14篇 |
1983年 | 26篇 |
1982年 | 20篇 |
1981年 | 20篇 |
1980年 | 28篇 |
1979年 | 12篇 |
1978年 | 11篇 |
1977年 | 14篇 |
1976年 | 10篇 |
1975年 | 21篇 |
1973年 | 5篇 |
1972年 | 4篇 |
1969年 | 4篇 |
排序方式: 共有1192条查询结果,搜索用时 15 毫秒
11.
Groopman JE; Hartzband PI; Shulman L; Salahuddin SZ; Sarngadharan MG; McLane MF; Essex M; Gallo R 《Blood》1985,66(3):742-744
The human T-lymphotropic virus type III (HTLV-III) is the primary cause of the acquired immunodeficiency syndrome (AIDS) and related disorders (ARC). Prior studies have reported that nearly all symptomatic patients with AIDS or ARC manifest antibody to HTLV-III. This observation has engendered efforts to screen for HTLV-III, especially prior to blood donation, with assays for antibody to HTLV-III. We report the first two cases, one with AIDS and one with ARC, that are HTLV-III virus positive but antibody negative. Accurate diagnosis of HTLV-III infection in some cases may require direct virus culture or tests for antigen. In addition, lack of HTLV-III antibody may indicate an atypical clinical course of AIDS. 相似文献
12.
13.
14.
15.
16.
17.
Ana Gvozdenovic Matthias JE Arlt Carmen Campanile Patrick Brennecke Knut Husmann Yufei Li Walter Born Roman Muff Bruno Fuchs 《Journal of bone and mineral research》2013,28(4):838-847
Formation of metastases in the lungs is the major cause of death in patients suffering from osteosarcoma (OS). Metastases at presentation and poor response to preoperative chemotherapy are strong predictors for poor patient outcome. The elucidation of molecular markers that promote metastasis formation and/or chemoresistance is therefore of importance. CD44 is a plasma membrane glycoprotein that binds to the extracellular matrix component hyaluronan (HA) and has been shown to be involved in metastasis formation in a variety of other tumors. Here we investigated the role of CD44 expression on OS tumor formation and metastasis. High CD44 expression, evaluated with a tissue microarray including samples from 53 OS patients and stained with a pan‐CD44 antibody (Hermes3), showed a tendency (p < 0.08) to shortened overall survival. However, nonresponders and patients with lung metastases and high CD44 expression had significantly poorer prognosis than patients with low CD44 expression. Overexpression of the standard CD44 isoform (CD44s) and its HA‐binding defective mutant R41A in osteoblastic SaOS‐2 cells resulted in HA‐independent higher migration rates and increased chemoresistance, partially dependent on HA. In an orthotopic mouse model of OS, overexpression of CD44s in SaOS‐2 cells resulted in an HA‐dependent increased primary tumor formation and increased numbers of micrometastases and macrometastases in the lungs. In conclusion, although CD44 failed to be an independent predictor for patient outcome in this limited cohort of OS patients, increased CD44 expression was associated with even worse survival in patients with chemoresistance and with lung metastases. CD44‐associated chemoresistance was also observed in vitro, and increased formation of lung metastases was found in vivo in SCID mice. © 2013 American Society for Bone and Mineral Research. 相似文献
18.
19.
20.